Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 4/20 | 0.54 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.54 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.52 |
| ▸ | NPY1R | P25929 | 1/20 | 0.52 |
| ▸ | NPY2R | P49146 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 1/20 | 0.52 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Laminin SCHEMBL29354054 | 0.90 | NTSR1 (0.56) | NTSR1NTSR2PTPN1NPY1RNPY2R | |
| Laminin SCHEMBL29359946 | 0.90 | NTSR1 (0.56) | NTSR1NTSR2PTPN1NPY1RNPY2R | |
| SCHEMBL29502171 | 0.88 | QRFPR (0.57) | NTSR1NTSR2PTPN1NPY1RNPY2R | |
| SCHEMBL31756855 | 0.87 | NTSR1 (0.66) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL30342513 | 0.83 | OPRD1 (0.57) | KISS1ROPRD1 | |
| SCHEMBL29389638 | 0.82 | NPY1R (0.65) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL29474946 | 0.82 | NPY1R (0.61) | NTSR1NTSR2KISS1RNPY1RNPY2R | |
| SCHEMBL29942466 | 0.81 | NPY1R (0.73) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL31366722 | 0.81 | BACE1 (0.54) | OPRD1 | |
| SCHEMBL30088888 | 0.80 | NPY1R (0.62) | NTSR1NTSR2PTPN1NPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540313-B2 | ADH protein family mutant and use thereof | KANGMA-HEALTHCODE (SHANGHAI) BIOTECH CO., LTD. (CN) | 2026-02-03 | — | — | US | disclosed |
| CN-110551700-B | ADH protein family mutant and application thereof | 康码（上海）生物科技有限公司 | 2022-06-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540313-B2 | ADH protein family mutant and use thereof | ADH1A, ADH1C, ADH5 | NTSR1 4434/4885NTSR2 4214/4885PCSK9 3748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.